It exhibited inhibitory effects against SARS‐CoV‐2 by interfering with binding of viral S‐protein and human angiotensin converting enzyme 2 (ACE2), thereby preventing the virus from entering host cells.[10] Furthermore, it may alleviate inflammation and modulate the host's immune response to improve virus‐induced lung injury.[11] In treating influenza, GGD exhibited notable efficacy by reducing H1N1 viral titers in vivo, demonstrating significant anti‐influenza A virus activity. The gene discussed is ACE2; the disease is influenza.